Middle East & Africa

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Middle East & Africa Analysis

Industry Trend Analysis - Underlying Regulatory Weaknesses to Weigh on Region's Attractiveness To Drugmakers - DEC 2017

Sub-Saharan Africa's (SSA)'s pharmaceutical regulatory landscape continues to face a number of challenges that shape a decidedly difficult environment for drugmakers. Wide dipartites in regulatory procedures, a lack of enforcement of patent laws, and a general lack of transparency ensure the SSA region lags behind other sub-regions globally. Led by South Africa, regulatory reforms and improved...

READ FULL ARTICLE...

Industry Trend Analysis - Weak Regulatory Standards Perpetuate A Challenging Drugmaker Environment - NOV 2017

Regulatory inefficiencies are characteristic of Sub-Saharan Africa's pharmaceutical markets, which will continue to present a key market access barrier for innovative drugmakers. Nuances exist at the country- level, and the gradual establishment of regulatory agencies is yielding a slowly improving regulatory environment in certain markets. However, a lack of enforcement and willingness from...

READ FULL ARTICLE...